Compare SHASUN PHARMA with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA DR. REDDYS LAB SHASUN PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 123.9 16.8 735.7% View Chart
P/BV x 8.5 3.2 264.5% View Chart
Dividend Yield % 0.2 0.7 31.8%  

Financials

 SHASUN PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
DR. REDDYS LAB
Mar-19
SHASUN PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs942,875 3.3%   
Low Rs461,888 2.4%   
Sales per share (Unadj.) Rs214.2930.2 23.0%  
Earnings per share (Unadj.) Rs5.3117.4 4.5%  
Cash flow per share (Unadj.) Rs15.8185.8 8.5%  
Dividends per share (Unadj.) Rs1.0020.00 5.0%  
Dividend yield (eoy) %1.40.8 170.4%  
Book value per share (Unadj.) Rs53.3844.4 6.3%  
Shares outstanding (eoy) m56.62166.07 34.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.32.6 12.7%   
Avg P/E ratio x13.120.3 64.6%  
P/CF ratio (eoy) x4.412.8 34.5%  
Price / Book Value ratio x1.32.8 46.5%  
Dividend payout %18.717.0 110.0%   
Avg Mkt Cap Rs m3,958395,496 1.0%   
No. of employees `000NA22.0 0.0%   
Total wages/salary Rs m2,16433,562 6.4%   
Avg. sales/employee Rs ThNM7,032.8-  
Avg. wages/employee Rs ThNM1,527.9-  
Avg. net profit/employee Rs ThNM887.7-  
INCOME DATA
Net Sales Rs m12,127154,482 7.9%  
Other income Rs m2293,375 6.8%   
Total revenues Rs m12,356157,857 7.8%   
Gross profit Rs m1,00931,782 3.2%  
Depreciation Rs m59411,348 5.2%   
Interest Rs m415889 46.7%   
Profit before tax Rs m23022,920 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 -0.1%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-733,858 -1.9%   
Profit after tax Rs m30219,500 1.5%  
Gross profit margin %8.320.6 40.4%  
Effective tax rate %-31.716.8 -188.1%   
Net profit margin %2.512.6 19.7%  
BALANCE SHEET DATA
Current assets Rs m6,884111,101 6.2%   
Current liabilities Rs m8,45658,973 14.3%   
Net working cap to sales %-13.033.7 -38.4%  
Current ratio x0.81.9 43.2%  
Inventory Days Days6279 77.7%  
Debtors Days Days10894 114.2%  
Net fixed assets Rs m4,970101,245 4.9%   
Share capital Rs m113830 13.7%   
"Free" reserves Rs m2,875139,406 2.1%   
Net worth Rs m3,020140,236 2.2%   
Long term debt Rs m1,81722,000 8.3%   
Total assets Rs m13,347224,656 5.9%  
Interest coverage x1.626.8 5.8%   
Debt to equity ratio x0.60.2 383.6%  
Sales to assets ratio x0.90.7 132.1%   
Return on assets %5.49.1 59.2%  
Return on equity %10.013.9 71.9%  
Return on capital %13.314.9 89.1%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84388,673 6.6%   
Fx outflow Rs m2,17319,104 11.4%   
Net fx Rs m3,66969,569 5.3%   
CASH FLOW
From Operations Rs m39828,704 1.4%  
From Investments Rs m-1,635-7,727 21.2%  
From Financial Activity Rs m1,309-21,326 -6.1%  
Net Cashflow Rs m71-314 -22.7%  

Share Holding

Indian Promoters % 39.2 25.5 153.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 5.4 66.7%  
FIIs % 17.6 35.3 49.9%  
ADR/GDR % 0.0 18.5 -  
Free float % 39.6 15.3 258.8%  
Shareholders   20,750 75,885 27.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS